fatty liver disease and semaglutide (Ozempic/Wegovy) dramatically improves Metabolic Dysfunction–Associated Steatotic Liver Disease

The major differences lie in mechanism and efficacy , not in how you administer the medication

These digestive side effects are typically temporary and should subside as your body gets used to the medication over the next few weeks

The litigation continues to focus on allegations that GLP-1 drugs like Ozempic, Wegovy, and Mounjaro caused severe gastrointestinal injuries, including gastroparesis and intestinal obstruction

The dual action creates a synergistic effect that may explain Zepbounds superior weight loss results

Weight regain cascades Once hunger returns, patients experience increased food noise that makes it harder for them to stay in maintenance